|
|
|
Volumn 28, Issue 6 SUPPL. 1, 1996, Pages 24-29
|
|
Update on preclinical and clinical experience with mycophenolate mofetil
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
CYTOKINE;
INOSINATE DEHYDROGENASE;
MYCOPHENOLIC ACID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
THYMOCYTE ANTIBODY;
ALLOGRAFT;
ANTIBODY PRODUCTION;
B LYMPHOCYTE ACTIVATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG SAFETY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
LYMPHOCYTE PROLIFERATION;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PURINE SYNTHESIS;
T LYMPHOCYTE ACTIVATION;
TREATMENT FAILURE;
ANIMALS;
CLINICAL TRIALS;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MYCOPHENOLIC ACID;
|
|
EID: 0029837983
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (26)
|
|
References (0)
|
